Skip to main content

 

Main menu

  • Home
  • Articles
    • Current Issue
    • Archive
    • Editorials
    • Immunology Education
    • Most Read
    • On The Horizon Collection
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Services
    • Email Alerts
    • RSS Feeds
  • More
    • AAI Disclaimer
    • Feedback
  • Other Publications
    • American Association of Immunologists
    • The Journal of Immunology

User menu

  • Log in

Search

  • Advanced search
ImmunoHorizons
  • Other Publications
    • American Association of Immunologists
    • The Journal of Immunology
  • Log in
ImmunoHorizons

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Archive
    • Editorials
    • Immunology Education
    • Most Read
    • On The Horizon Collection
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Services
    • Email Alerts
    • RSS Feeds
  • More
    • AAI Disclaimer
    • Feedback
  • Follow ImmunoHorizons on Twitter
  • Follow ImmunoHorizons on RSS
Open Access

DPI Selectively Inhibits Intracellular NADPH Oxidase Activity in Human Neutrophils

Alicia Buck, Felix P. Sanchez Klose, Vignesh Venkatakrishnan, Arsham Khamzeh, Claes Dahlgren, Karin Christenson and Johan Bylund
ImmunoHorizons October 1, 2019, 3 (10) 488-497; DOI: https://doi.org/10.4049/immunohorizons.1900062
Alicia Buck
*Department of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy at University of Gothenburg, 40530 Gothenburg, Sweden; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alicia Buck
Felix P. Sanchez Klose
*Department of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy at University of Gothenburg, 40530 Gothenburg, Sweden; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Felix P. Sanchez Klose
Vignesh Venkatakrishnan
†Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, 40530 Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arsham Khamzeh
*Department of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy at University of Gothenburg, 40530 Gothenburg, Sweden; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claes Dahlgren
†Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, 40530 Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karin Christenson
*Department of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy at University of Gothenburg, 40530 Gothenburg, Sweden; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johan Bylund
*Department of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy at University of Gothenburg, 40530 Gothenburg, Sweden; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Johan Bylund
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Both DPI and GSK inhibit superoxide release from human neutrophils as measured by cytochrome c reduction.

    Shown is a representative experiment (A) with cells preincubated for 5 min with buffer (KRG) or 27 μM indicated inhibitor before stimulation with PMA (50 nM; arrow), and a dose–response graph (B) displaying PMA-triggered superoxide release (as compared with samples in the absence of inhibitor) in the presence of indicated concentrations of DPI (triangles) or GSK (circles) as mean ± SD of three independent experiments. Negative control values obtained from PMA-stimulated samples in the presence of SOD were subtracted, and the 100% response value (no inhibitor) was set to x values of 10−9 M to be able to present the data on a logarithmic axis. Statistical differences between GSK and DPI are indicated. (C) Neither inhibitor caused general cell damage, as cells treated with high concentrations of inhibitors (40 μM) were perfectly capable of intracellular calcium signaling in response to chemoattractant stimulation. Representative calcium transients (out of at least three independent experiments) are shown, and arrows indicate the time points for addition of fMLF (10 nM). ***p < 0.001.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    ROS production at distinct sites.

    PMA stimulation of human neutrophils results in ROS production at two distinct sites, extracellular and intracellular, that can be measured independently by isoluminol- and luminol-enhanced CL, respectively (A). High doses (10 μM) of either GSK or DPI blocked EC as well as IC ROS production (B). Representative (out of at least 10 independent experiments) curves are shown (left), and bar diagrams (right) compare peak values (mean + SD; n = 3) after PMA stimulation in the presence or absence of inhibitors (10 μM), with statistical significance (using paired Student t tests) for each inhibitor as compared with controls with KRG buffer instead of inhibitor. Cells were incubated with inhibitors for 5 min at 37°C before stimulation with PMA. EC, extracellular; IC, intracellular. ***p < 0.001.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Inhibition of extracellular and intracellular ROS production induced by PMA.

    Dose–response curves for inhibition of PMA-stimulated extracellular versus intracellular ROS production by GSK (A) or DPI (B). The 100% response value (no inhibitor) was set to x values of 10−10 M to be able to present the data on a logarithmic axis. Cells were incubated with inhibitors for 5 min at 37°C before stimulation with PMA. Shown are mean ROS peak values as percentages of control ± SD of three independent experiments performed in triplicate. Statistically significant differences between the EC and IC responses are indicated for each inhibitor dose. EC, extracellular; IC, intracellular. **p < 0.01, ***p < 0.001.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Inhibition of extracellular and intracellular ROS production induced by fMLF or phagocytosis.

    Dose–response curves for inhibition of fMLF-stimulated extracellular versus S. aureus–triggered intracellular ROS production by DPI (A). Cells were incubated with inhibitor for 5 min at 37°C before stimulation. Shown are mean ROS peak values as percentages of control ± SEM of three independent experiments in triplicate. Statistically significant differences between the EC and IC responses are indicated for each inhibitor dose. The 100% response value (no inhibitor) was set to x values of 10−10 M to be able to present the data on a logarithmic axis. (B) DPI (10 μM) did not decrease MPO activity in neutrophil lysates. Shown are mean + SD of three independent experiments. EC, extracellular; IC, intracellular. ***p < 0.001.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Kinetics of NADPH oxidase inhibition.

    Kinetics of the inhibitory effects of DPI (A) and GSK (B) on the extracellular (solid lines) and intracellular (dotted lines) NADPH oxidase. Each inhibitor (20 μM) was injected (arrows) during PMA-triggered ROS production, and the CL responses were followed; note that x-axes display s. Shown are representative curves out of at least four independent experiments. EC, extracellular; IC, intracellular.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Reversibility of ROS production.

    Reversibility of ROS production after washing away GSK (black) or DPI (white). (A) Cells were incubated with each inhibitor (20 μM) for 5 min and then washed three times with inhibitor-free buffer before being assayed for extracellular (left) and intracellular (right) ROS production in response to PMA. Shown are mean + SD of ROS peak values obtained from four independent experiments. The response of control cells incubated with buffer (KRG) before being subjected to the same washing procedure and PMA stimulation is set to 100%. Statistical significance between GSK and DPI was calculated by paired Student t tests. (B) That the inhibitory effect of DPI on extracellular ROS production could be washed away was ascertained by cytochrome c reduction assay. Cells were incubated with DPI (20 μM) for 5 min and then washed and stimulated with PMA in the presence or absence of new DPI (20 μM). The graph displays mean Δ values (max OD − initial OD) + SD from two independent experiments performed in triplicate. Statistical significance was calculated by an unpaired t test. *p < 0.05, ***p < 0.001.

Additional Files

  • Figures
  • Data Supplement

    • Supplemental Table (PDF)
PreviousNext
Back to top

In this issue

ImmunoHorizons: 3 (10)
ImmunoHorizons
Vol. 3, Issue 10
1 Oct 2019
  • Table of Contents
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about ImmunoHorizons.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
DPI Selectively Inhibits Intracellular NADPH Oxidase Activity in Human Neutrophils
(Your Name) has forwarded a page to you from ImmunoHorizons
(Your Name) thought you would like to see this page from the ImmunoHorizons web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
DPI Selectively Inhibits Intracellular NADPH Oxidase Activity in Human Neutrophils
Alicia Buck, Felix P. Sanchez Klose, Vignesh Venkatakrishnan, Arsham Khamzeh, Claes Dahlgren, Karin Christenson, Johan Bylund
ImmunoHorizons October 1, 2019, 3 (10) 488-497; DOI: 10.4049/immunohorizons.1900062

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
DPI Selectively Inhibits Intracellular NADPH Oxidase Activity in Human Neutrophils
Alicia Buck, Felix P. Sanchez Klose, Vignesh Venkatakrishnan, Arsham Khamzeh, Claes Dahlgren, Karin Christenson, Johan Bylund
ImmunoHorizons October 1, 2019, 3 (10) 488-497; DOI: 10.4049/immunohorizons.1900062
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Caspase-8 Blocks Receptor-Interacting Protein Kinase-1 Kinase–Independent Necroptosis during Embryogenesis
  • Systems Immunology Analyses of STAT1 Gain-of-Function Immune Phenotypes Reveal Heterogeneous Response to IL-6 and Broad Immunometabolic Roles for STAT1
  • Transcriptional and Cytotoxic Responses of Human Intestinal Organoids to IFN Types I, II, and III
Show more INNATE IMMUNITY

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds

Copyright© 2022 by The American Association of Immunologists, Inc

Online ISSN 2573-7732